Chisako Iriyama

640 total citations
17 papers, 329 citations indexed

About

Chisako Iriyama is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Chisako Iriyama has authored 17 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Chisako Iriyama's work include Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Chisako Iriyama is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Chisako Iriyama collaborates with scholars based in Japan and United Kingdom. Chisako Iriyama's co-authors include Hitoshi Kiyoi, Akihiro Tomita, Mark S. Cragg, Kazuyuki Shimada, Matthew Rose‐Zerilli, Chantal E. Hargreaves, Lee R. Machado, Edward J. Hollox, Jonathan C. Strefford and Satoru Matsuda and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Immunological Reviews.

In The Last Decade

Chisako Iriyama

17 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chisako Iriyama Japan 10 154 106 92 81 77 17 329
Chuen‐Miin Leu Taiwan 8 158 1.0× 169 1.6× 80 0.9× 69 0.9× 52 0.7× 12 374
Diane Razanajaona France 11 171 1.1× 323 3.0× 91 1.0× 95 1.2× 51 0.7× 15 486
Sonya H.L. Lam Canada 10 292 1.9× 75 0.7× 32 0.3× 185 2.3× 93 1.2× 15 466
Jing Christine Ye United States 7 89 0.6× 61 0.6× 44 0.5× 139 1.7× 30 0.4× 20 262
Erica Hansen United States 7 445 2.9× 213 2.0× 35 0.4× 108 1.3× 121 1.6× 11 618
J Black United States 7 81 0.5× 157 1.5× 28 0.3× 64 0.8× 73 0.9× 10 320
Carol Meschonat United States 12 323 2.1× 64 0.6× 47 0.5× 107 1.3× 82 1.1× 16 420
Koorosh Korfi United Kingdom 8 228 1.5× 72 0.7× 42 0.5× 148 1.8× 81 1.1× 18 549
Hans G. Drexler Germany 9 180 1.2× 150 1.4× 32 0.3× 154 1.9× 44 0.6× 11 485
Christine Mione Kiefer United States 12 457 3.0× 45 0.4× 55 0.6× 125 1.5× 58 0.8× 16 618

Countries citing papers authored by Chisako Iriyama

Since Specialization
Citations

This map shows the geographic impact of Chisako Iriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chisako Iriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chisako Iriyama more than expected).

Fields of papers citing papers by Chisako Iriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chisako Iriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chisako Iriyama. The network helps show where Chisako Iriyama may publish in the future.

Co-authorship network of co-authors of Chisako Iriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Chisako Iriyama. A scholar is included among the top collaborators of Chisako Iriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chisako Iriyama. Chisako Iriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Iriyama, Chisako, Akinao Okamoto, Naoe Goto, et al.. (2023). Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases. Cancer Medicine. 12(16). 16972–16984. 5 indexed citations
2.
Abe, Akihiro, Yukiya Yamamoto, Akira Katsumi, et al.. (2020). Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor. Cytogenetic and Genome Research. 160(5). 255–263. 4 indexed citations
3.
Inoue, Hiroyasu, Hirofumi Taji, Chisako Iriyama, et al.. (2020). Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia. Internal Medicine. 59(19). 2419–2421. 3 indexed citations
4.
Sakamoto, Akihiko, Kazuyuki Shimada, Makoto Tsunoda, et al.. (2018). Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells. Cancer Science. 110(1). 269–278. 46 indexed citations
5.
Iriyama, Chisako, et al.. (2017). Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome. Leukemia Research. 63. 90–97. 20 indexed citations
6.
Ogawa, Yasushi, et al.. (2016). Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoma in a Patient Receiving Therapy with Anti-Tumour Necrosis Factor and Thiopurine. Acta Dermato Venereologica. 97(2). 273–274. 2 indexed citations
7.
Suzuki, Yasuhíro, Akihiro Tomita, Fumika Nakamura, et al.. (2016). Peripheral blood cell‐free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes. Cancer Science. 107(9). 1329–1337. 14 indexed citations
8.
Aoki, Tomohiro, Kazuyuki Shimada, Akihiko Sakamoto, et al.. (2016). Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism. Oncotarget. 8(8). 13085–13098. 19 indexed citations
9.
Aoki, Tomohiro, Kazuyuki Shimada, Akihiko Sakamoto, et al.. (2016). Emetine Elicits Apoptosis of Intractable B-Cell Lymphoma Cells with MYC Rearrangement through Inhibition of Glycolytic Metabolism. Blood. 128(22). 3019–3019. 5 indexed citations
10.
Hargreaves, Chantal E., Matthew Rose‐Zerilli, Lee R. Machado, et al.. (2015). Fcγ receptors: genetic variation, function, and disease. Immunological Reviews. 268(1). 6–24. 69 indexed citations
11.
12.
Vaughan, Andrew, Chisako Iriyama, Stephen A. Beers, et al.. (2013). Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity. Blood. 123(5). 669–677. 56 indexed citations
13.
Iriyama, Chisako, Akihiro Tomita, Yoko Furukawa‐Hibi, et al.. (2012). Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome. Biochemical and Biophysical Research Communications. 419(4). 662–669. 21 indexed citations
14.
Kato, Tomonori, Seitaro Terakura, Makoto Murata, et al.. (2012). Escape of leukemia blasts from HLA-specific CTL pressure in a recipient of HLA one locus-mismatched bone marrow transplantation. Cellular Immunology. 276(1-2). 75–82. 2 indexed citations
15.
Sakai, Katsuya, Yuichi Ishikawa, Yumiko Mori, et al.. (2011). A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis. International Journal of Hematology. 93(2). 237–242. 7 indexed citations
16.
Iriyama, Chisako, Satoru Matsuda, Ryoichi Katsumata, & Motohiro Hamaguchi. (2001). Cloning and sequencing of a novel human gene which encodes a putative hydroxylase. Journal of Human Genetics. 46(5). 289–292. 17 indexed citations
17.
Matsuda, Satoru, Chisako Iriyama, Naoki Shirafuji, et al.. (2001). Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3. Journal of Human Genetics. 46(8). 483–486. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026